MetaSight
AcquiredTel Aviv, Israel · $8.0M raised
- Headquarters
- Tel Aviv
- Employees
- 11–50
- Business Model
- B2B
- Website
- metasightdx.com
- Total Funding
- $8.0M
- Last Round
- $8.0M Series ANov 2024
- Rounds
- 1
- Acquired by
- Guardant HealthFeb 2026
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.
About
Develops blood-based metabolomic diagnostics to detect colorectal and other cancers for healthcare providers.
Summary
MetaSight is a Diagnostics company based in Tel Aviv, Israel. It has raised $8.0M in total across 1 round, most recently a $8.0M Series A round in Nov 2024. Investors include Guardant Health, aMoon and Saban Ventures.
Funding & Exit History
Feb 2026
Sign up to see all 2 events
Funding: Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Provides genomic profiling tests and data services to oncologists and biopharma partners to guide...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/metasight"><img src="https://indexed.vc/api/badge/company/metasight" alt="MetaSight on Indexed.vc" width="260" height="76" /></a>